Answers are grounded in this paper and cite their sources.
We read with interest a recent article in this journal regarding co-infections in people with COVID-19.1 Rapid and simultaneous detection of SARS-CoV-2, the cause of COVID-19, and co-infections is essential for clinical management of COVID-19 patients. However, the diversity of possible co-infecting pathogens (bacteria and viruses) challenges conventional diagnostics approaches (bacterial culture and PCR). Metagenomics is a sensitive pan-pathogen assay for infectious disease diagnosis and the discovery of novel pathogens.
No takes yet. Share an insight, caveat, or question.
Tan et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: